drugset / Trial / NCT03725033
Clinical Trial of Efficacy and Safety of Subetta in the Treatment of Impaired Glucose Tolerance
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Purpose of the study: * to assess the efficacy of Subetta in the treatment of impaired glucose tolerance * to assess the safety of Subetta in the treatment of impaired glucose tolerance.
Timeline
- Start
- 2018-10-10
- Primary completion
- 2020-03-23
- Completion
- 2020-03-23
Outcome
Met primary endpoint
registry analysis (superiority test); Subetta vs Placebo; p = 0.0028; Wilcoxon (Mann-Whitney) NCT03725033 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Subetta | Protein / enzyme biologic | — | Oral |